Retrospective analysis of long-term surgical results in acromegaly: Preoperative and postoperative factors predicting outcome

Clinical Endocrinology

Volumn 45, Issue 3, 1996, Pages 291-298

  Yamada, Shozo ^a   Aiba, Tadashi ^a   Takada, Kouji ^a   Ozawa, Yasunori ^a   Shimizu, Taeko ^a   Sawano, Shinji ^a   Shishiba, Yoshimasa ^a   Sano, Toshiaki ^b  

^a TORANOMON HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029791022     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.8080817.x     Document Type: Article

References (38)

1. Arafah, B.M., Rosenzweig, J.L., Fenstermaker, R., Salazar, R., McBride, C.E. & Selman, W. (1987) Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. Journal of Laboratory and Clinical Medicine, 109, 346-354.
2. Arosio, M., Giovanelli, M.A., Riva, E., Ambrosi, B. & Faglia, G. (1983) Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly. Journal of Neurosurgery, 9, 402-408.
3. Balagura, S., Derome, P. & Guiot, G. (1981) Acromegaly: analysis of 132 cases treated surgically. Neurosurgery, 8, 413-416.
4. Barkan, A.L., Beitins, I.Z. & Kelch, R.P. (1988) Plasma insulin-like growth factor-1/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. Journal of Clinical Endocrinology and Metabolism, 67, 69-73.
5. Bynke, O., Karlberg, B.E., Kagedal, B. & Nilsson, O.R. (1983) Early postoperative growth hormone levels predict the result of transsphernoidal tumour removal in acromegaly. Acta Endocrinologica (Copenhagen), 103, 158-162.
6. Daughaday, W.H., Mariz, I.K. & Blethen, S.L. (1980) Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. Journal of Clinical Endocrinology and Metabolism, 51, 781-788.
7. Davis, D.H., Laws, E.R. Jr, Ilstrup, D.M., Speed, J.K., Caruso, M., Shaw, E.G., Abbout, C.F., Scheithauer, B.W., Root, L.M. & Schleck, C. (1993) Results of surgical treatment for growth hormone-secreting pituitary adenomas. Journal of Neurosurgery, 79, 70-75.
8. De-Marinis, L., Mancini, A., Zuppi, P., Anile, C. & Maira, G. (1990) Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value. Acta Endocrinologica, 122, 433-449.
9. Dixon, W.J., Brown, M.B., Engleman, L., Frane, J.W., Hill, M.A., Jennrich, R.I. & Toporek, J.D. (1985) BMDP Statistical Software. University of California Press, Berkeley.
10. Fahlbusch, R., Honegger, J. & Buchfelder, M. (1992) Surgical management of acromegaly. Endocrinology and Metabolism Clinics of North America, 21, 669-692.
11. Giannella-Neto, D., Wajchenberg, B.L., Mendonca, B.B., Almeida, S.F., Macchione, M. & Spencer, E.M. (1988) Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients. Journal of Endocrinological Investigation, 11, 57-60.
12. Grisoli, F., Leclercq, T., Jaquet, P., Guibout, M., Winteler, J.P., Hassoun, J. & Vincentelli, F. (1985) Transsphenoidal surgery for acromegaly: long-term results in 100 patients. Surgical Neurology, 23, 513-519.
13. Hardy, J. & Vezina, J.L. (1976) Transsphenoidal neurosurgery of intracranial neoplasm. In Advances in Neurology (ed. R.A. Thomson & J.R. Gree), pp. 261-274. Raven Press, New York.
14. Irie, M. & Tsushima, T. (1972) Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegally or gigantism. Journal of Clinical Endocriinology and Metabolism, 35, 97-100.
15. Jaquet, P., Guibout, M., Jaquet, C., Grisoli, F., Devolx, B.C., Dumas, D. & Bert, J. (1980) Circadian regulation of growth hormone secretion after treatment in acromegaly. Journal of Clinical Endocrinology and Metabolism, 50, 322-328.
16. Kao, P.C., Laws, E.R. Jr & Zimmerman, D. (1992) Somatomedin C/insulin-like growth factor 1 levels after treatment of acromegaly. Annals of Clinical and Laboratory Science, 22, 95-99.
17. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation for incomplete observation. Journal of the American Statistical Association, 53, 457-481.
18. Kitano, M., Shimizu, T., Yamazaki, Y., Umezu, Y., Arakawa, Y. & Daimon, Y. (1995) Serum insulin-like growth factor-1 (IGK-I) in normal Japanese adults. Endocrine Journal, 42, 767-770.
19. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Rosen, T., Lindstedt, G., Lundberg, P.A. & Bengtsson, B.A. (1994) Serum insulin-like growth factor 1 in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology, 41, 351-357.
20. Lindholm, J., Giwercman, B., Giwercman, A., Astrup, J., Bjerre, P. & Shakkebaek, N.E. (1987) Investigation of the criteria for assessing the outcome of treatment in acromegaly. Clinical Endocrinology, 27, 553-562.
21. Losa, M., Oeckler, R., Schopohl, J., Muller, A., Alba-Lopez, J. & Von Werder, K. (1989) Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. Journal of Neurosurgery, 70, 561-567.
22. Melmed, S. (1990) Acromegaly. New England Journal of Medicine, 322, 966-977.
23. Melmed, S., Braunstein, G.D., Chang, R.J. & Becker, D.P. (1986) Pituitary tumors secreting growth hormone and prolactin. Annals of Internal Medicine, 105, 238-253.
24. Osman, I.A., James, R.A., Chatterjee, S., Mathias, D. & Kendall-Taylor, P. (1994) Factors determining the long-term outcome of surgery for acromegaly. Quarterly Journal of Medicine, 87, 617-623.
25. Oyen, W.J.G., Pieters, G.F.M., Meijer, F., Laarhoven, J.V., Smals, A.G.H. & Kloppenborg, P.W.C. (1988) Which factors predict the results of pituitary surgery in acromegaly? Acta Endocrinologica, 117, 491-496.
26. Roelfsema, F., Van Dulken, H. & Frolich, M. (1985) Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clinical Endocrinology, 23, 555-565.
27. Roelfsema, F., Frolich, M. & Van Dulken, H. (1987) Somatomedin-C levels in treated and untreated patients with acromegaly. Clinical Endocrinology, 26, 137-144.
28. Schuster, L. Banter, J. P., Oppenheimer, J.H. & Seljeskog, E.L. (1981) Acromegaly: reassessment of the long-term therapeutic effectiveness of transsphenoidal pituitary surgery. Annals of Internal Medicine, 95, 172-174.
29. Serri, O., Somma, M., Comtois, R., Rasio, E., Beauregard, H., Jilwan, N. & Hardy, J. (1985) Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. Journal of Clinical Endocrinology and Metabolism, 61, 1185-1189.
30. Tindall, G.T. & Tindall, S.C. (1984) Transsphenoidal surgery for acromegaly: long-term results in 50 patients. In Progress in Endocrine Research and Therapy. Vol 1. Secretory Tumors of the Pituitary Gland (ed. P.M. Black, N.T. Zervas & E.C. Ridgway), pp. 175-178. Raven Press, New York.
31. Tindall, G.T., Oyesiku, N.M., Watts, N.B., Clark, R.V. Christy, J.H. & Adams, D.A. (1993) Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. Journal of Neurosurgery, 78, 205-215.
32. Tucker, H.S.G., Grubb, S.R., Wigand, J.P., Watlington, C.O., Blackard, W.G. & Becker, D.P. (1980) The treatment of acromegaly by transsphenoidal surgery. Archives of Internal Medicine, 140, 795-802.
33. Valdemarsson, S., Bramnert, M., Cronquist, S., Elner, A., Eneroth, C.M., Hedner, P., Lindvall-Alelsson, M., Nordstrom, C.H. & Stromblad, L.G. (1991) Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients. Journal of Internal Medicine, 230, 49-54.
34. Van't Verlaat, J.W., Nortier, J.W.R., Hendriks, M.J., Bosma, N.J., Graamans, K., Lubsen, H., Vasen, H.F.A., Thijssen, J.H.H. & Croughs, R.J.M. (1988) Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up. Acta Endocrinologica, 117, 154-158.
35. Watanabe, M., Kuwayama, A., Nakane, T., Kanie, N., Kato, T., Takahashi, T. & Kageyama, N. (1985) Long-term growth hormone responses to non-specific hypothalamic hormones in acromegalic patients. Surgical Neurology, 24, 449-456.
36. Wilson, C.B. (1984) A decade of pituitary microsurgery. The Herbert Olivecrona Lecture. Journal of Neurosurgery, 61, 814-833.
37. Yamada, S., Aiba, T. & Shishiba, Y. (1989) Postoperative prognostic indicators of control of acromegaly. Surgical Neurology, 31, 14-19.
38. Yamada, S., Aiba, T., Sano, T., Kovacs, K., Shishiba, Y., Sawano, S. & Takada, K. (1993) Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery, 33, 20-27.